Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keefer

Showing results (1031-1040 of 1,129) with videos related to

Pageof 113
Sort By:
The American Journal of Gastroenterology|January 29, 2020
Esophageal Hypervigilance and Visceral Anxiety Are Contributors to Symptom Severity Among Patients Evaluated With High-Resolution Esophageal ManometryDustin A Carlson, C Prakash Gyawali, Sabine Roman, et al.
Molecular Cancer Therapeutics|April 18, 2003
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activityPaul J Shami, Joseph E Saavedra, Lai Y Wang, et al.
Clinical Pharmacology and Therapeutics|October 17, 2019
Electronic Health Record-Embedded Decision Support Platform for Morphine Precision Dosing in NeonatesAlexander A Vinks, Nieko C Punt, Frank Menke, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 14, 1997
Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trialF M Hecht, J Wheat, A H Korzun, et al.
Cell Death & Disease|April 22, 2020
Transient receptor potential ion channel TRPM2 promotes AML proliferation and survival through modulation of mitochondrial function, ROS, and autophagyShu-Jen Chen, Lei Bao, Kerry Keefer, et al.
Inflammatory Bowel Diseases|May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease CourseStephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
General Hospital Psychiatry|January 21, 2023
Positive psychological well-being and clinical characteristics in IBS: A systematic reviewElizabeth N Madva, Monika Sadlonova, Lauren E Harnedy, et al.
The Journal of Infectious Diseases|July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteersT G Evans, M C Keefer, K J Weinhold, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022AKalpana Gupta, Michael Hudgens, Lawrence Corey, et al.
Pageof 113

Showing results (1031-1040 of 1,129) with videos related to

Sort By:
Pageof 113
The American Journal of Gastroenterology|January 29, 2020
Esophageal Hypervigilance and Visceral Anxiety Are Contributors to Symptom Severity Among Patients Evaluated With High-Resolution Esophageal ManometryDustin A Carlson, C Prakash Gyawali, Sabine Roman, et al.
Molecular Cancer Therapeutics|April 18, 2003
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activityPaul J Shami, Joseph E Saavedra, Lai Y Wang, et al.
Clinical Pharmacology and Therapeutics|October 17, 2019
Electronic Health Record-Embedded Decision Support Platform for Morphine Precision Dosing in NeonatesAlexander A Vinks, Nieko C Punt, Frank Menke, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 14, 1997
Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trialF M Hecht, J Wheat, A H Korzun, et al.
Cell Death & Disease|April 22, 2020
Transient receptor potential ion channel TRPM2 promotes AML proliferation and survival through modulation of mitochondrial function, ROS, and autophagyShu-Jen Chen, Lei Bao, Kerry Keefer, et al.
Inflammatory Bowel Diseases|May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease CourseStephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
General Hospital Psychiatry|January 21, 2023
Positive psychological well-being and clinical characteristics in IBS: A systematic reviewElizabeth N Madva, Monika Sadlonova, Lauren E Harnedy, et al.
The Journal of Infectious Diseases|July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteersT G Evans, M C Keefer, K J Weinhold, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022AKalpana Gupta, Michael Hudgens, Lawrence Corey, et al.
Pageof 113